Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study

被引:34
|
作者
Hall, Anna [1 ]
Crichton, Siobhan [2 ]
Dixon, Alison [1 ]
Skorniakov, Ilia [3 ]
Kellum, John A. [4 ]
Ostermann, Marlies [5 ]
机构
[1] Guys & St Thomas Hosp, Dept Crit Care, London, England
[2] UCL, Clin Trials Unit, MRC, London, England
[3] Sverdlovsk Reg Clin Hosp 1, Dept Nephrol & Dialysis, Ekaterinburg, Russia
[4] Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA USA
[5] Kings Coll London, Guys & St Thomas Hosp, Dept Crit Care, Westminster Bridge Rd, London SE1 7EH, England
来源
CRITICAL CARE | 2020年 / 24卷 / 01期
关键词
Renal replacement therapy; Acute kidney injury; Fluid balance; Fluid management; Ultrafiltration; Fluid removal; MANAGEMENT;
D O I
10.1186/s13054-020-02986-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Fluid overload is associated with morbidity and mortality in patients receiving renal replacement therapy (RRT). We aimed to explore whether fluid overload at initiation of RRT was independently associated with mortality and whether changes in cumulative fluid balance during RRT were associated with outcome. Methods We retrospectively analysed the data of patients who were admitted to the multidisciplinary adult intensive care unit (ICU) in a tertiary care centre in the UK between 2012 and 2015 and received continuous RRT (CRRT) for acute kidney injury for at least 24 h. We collected baseline demographics, body mass index (BMI), comorbidities, severity of illness, laboratory parameters at CRRT initiation, daily cumulative fluid balance (FB), daily prescribed FB target, fluid bolus and diuretic administration and outcomes. The day of the lowest cumulative FB during CRRT was identified as nadir FB. Results Eight hundred twenty patients were analysed (median age 65 years; 49% female). At CRRT initiation, the median cumulative FB was + 1772 ml; 89 patients (10.9%) had a cumulative FB > 10% body weight (BW). Hospital survivors had a significantly lower cumulative FB at CRRT initiation compared to patients who died (1495 versus 2184 ml; p < 0.001). In the 7 days after CRRT initiation, hospital survivors had a significant decline in cumulative FB (mean decrease 473 ml per day, p < 0.001) whilst there was no significant change in cumulative FB in non-survivors (mean decrease 112 ml per day, p = 0.188). Higher severity of illness at CRRT initiation, shorter duration of CRRT, the number of days without a prescribed FB target and need for higher doses of noradrenaline were independent risk factors for not reaching a FB nadir during CRRT. Multivariable analysis showed that older age, lower BMI, higher severity of illness, need for higher doses of noradrenaline and smaller reductions in cumulative FB during CRRT were independent risk factors for ICU and hospital mortality. Cumulative FB at CRRT initiation was not independently associated with mortality. Conclusion In adult patients receiving CRRT, a decrease in cumulative FB was independently associated with lower mortality. Fluid overload and need for vasopressor support at CRRT initiation were not independently associated with mortality after correction for severity of illness.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Early net ultrafiltration rate and mortality in critically ill patients receiving continuous renal replacement therapy
    Naorungroj, Thummaporn
    Serpa Neto, Ary
    Zwakman-Hessels, Lara
    Yanase, Fumitaka
    Eastwood, Glenn
    Murugan, Raghavan
    Kellum, John A.
    Bellomo, Rinaldo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (06) : 1112 - 1119
  • [42] Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study
    Chaijamorn, Weerachai
    Charoensareerat, Taniya
    Srisawat, Nattachai
    Pattharachayakul, Sutthiporn
    Boonpeng, Apinya
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [43] High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy
    De Pascale, Gennaro
    Lisi, Lucia
    Cutuli, Salvatore Lucio
    Marinozzi, Carlotta
    Palladini, Altea
    Ferrando, Elena Sancho
    Tanzarella, Eloisa Sofia
    Lombardi, Gianmarco
    Grieco, Domenico Luca
    Caroli, Alessandro
    Xhemalaj, Rikardo
    Cascarano, Laura
    Ciotti, Gabriella Maria Pia
    Sandroni, Claudio
    Sanguinetti, Maurizio
    Navarra, Pierluigi
    Antonelli, Massimo
    ANNALS OF INTENSIVE CARE, 2024, 14 (01):
  • [44] Associations of continuous anionic gap detection with the mortality in critically ill patients receiving renal replacement therapy
    Zhai, Yiling
    Luo, Changjun
    Zhou, Tao
    Zeng, Guangzhi
    Huang, Qiongyan
    Li, Jun
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (11) : 2967 - 2980
  • [45] CITRATE PHARMACOKINETCS IN ACUTE LIVER FAILURE CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS RENAL REPLACEMENT THERAPY
    Thanapongsatorn, Peerapat
    Sirivongrangson, Phatadon
    Lumlertgul, Nuttha
    Peerapornratana, Sadudee
    Srisawat, Nattachai
    Chaijamorn, Weerachai
    NEPHROLOGY, 2020, 25 : 38 - 38
  • [46] Continuous Renal Replacement Therapy Liberation and Outcomes of Critically Ill Patients With Acute Kidney Injury
    Liu, Chang
    Peng, Zhiyong
    Dong, Yue
    Li, Zhuo
    Song, Xuan
    Liu, Xinyan
    Andrijasevic, Nicole M.
    Gajic, Ognjen
    Albright, Robert C., Jr.
    Kashani, Kianoush B.
    MAYO CLINIC PROCEEDINGS, 2021, 96 (11) : 2757 - 2767
  • [47] Characteristics and Clinical Outcomes of Prolonged Continuous Renal Replacement Therapy in Critically Ill Pediatric Patients
    Pekkucuksen, Naile Tufan
    Arikan, Ayse Akcan
    Swartz, Sarah J.
    Srivaths, Poyyapakkam
    Angelo, Joseph R.
    PEDIATRIC CRITICAL CARE MEDICINE, 2020, 21 (06) : 571 - 577
  • [48] Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
    Broeker, A.
    Wicha, S. G.
    Dorn, C.
    Kratzer, A.
    Schleibinger, M.
    Kees, F.
    Heininger, A.
    Kees, M. G.
    Haeberle, H.
    CRITICAL CARE, 2018, 22
  • [49] Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
    A. Broeker
    S. G. Wicha
    C. Dorn
    A. Kratzer
    M. Schleibinger
    F. Kees
    A. Heininger
    M. G. Kees
    H. Häberle
    Critical Care, 22
  • [50] CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL CHILDREN RECEIVING EXTRACORPOREAL MEMBRANE OXYGENATION
    Koh, P. L.
    Lau, Y. W. P.
    Goh, S. G.
    MacLaren, G.
    PEDIATRIC NEPHROLOGY, 2015, 30 (12) : 2244 - 2244